Cigna (NYSE:CI – Get Rating) had its price objective lifted by The Goldman Sachs Group from $273.00 to $311.00 in a report released on Tuesday morning, Stock Target Advisor reports. They currently have a neutral rating on the health services provider's stock.

A number of other research firms also recently weighed in on CI. Sanford C. Bernstein upped their target price on Cigna from $258.00 to $301.00 and gave the stock a mkt perform rating in a research report on Friday, May 27th. Oppenheimer upped their price objective on Cigna from $310.00 to $320.00 and gave the company an outperform rating in a report on Monday. Mizuho boosted their price target on shares of Cigna from $291.00 to $330.00 and gave the stock a buy rating in a research report on Friday, August 5th. Truist Financial raised their price objective on shares of Cigna from $310.00 to $330.00 and gave the company a buy rating in a research report on Thursday, July 14th. Finally, BMO Capital Markets boosted their target price on shares of Cigna from $300.00 to $320.00 in a report on Monday, May 9th. Seven investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average target price of $304.67.

Cigna Trading Down 0.4 %

Shares of CI stock opened at $286.00 on Tuesday. Cigna has a 1 year low of $191.74 and a 1 year high of $289.63. The firm has a market capitalization of $87.26 billion, a PE ratio of 17.05, a price-to-earnings-growth ratio of 1.12 and a beta of 0.73. The stock has a fifty day moving average of $266.54 and a two-hundred day moving average of $252.56. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.72 and a current ratio of 0.72.

Cigna Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 22nd. Investors of record on Wednesday, September 7th will be paid a $1.12 dividend. This represents a $4.48 annualized dividend and a dividend yield of 1.57%. The ex-dividend date is Tuesday, September 6th. Cigna's payout ratio is presently 26.71%.

Insiders Place Their Bets

In other news, SVP Hoeltzel Mary T. Agoglia sold 7,044 shares of the company's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $286.89, for a total transaction of $2,020,853.16. Following the completion of the sale, the senior vice president now owns 8,498 shares in the company, valued at approximately $2,437,991.22. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, SVP Hoeltzel Mary T. Agoglia sold 7,044 shares of the business's stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $286.89, for a total value of $2,020,853.16. Following the completion of the sale, the senior vice president now directly owns 8,498 shares in the company, valued at $2,437,991.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Nicole S. Jones sold 5,901 shares of the firm's stock in a transaction on Tuesday, May 17th. The shares were sold at an average price of $270.00, for a total transaction of $1,593,270.00. Following the completion of the transaction, the executive vice president now owns 36,908 shares in the company, valued at $9,965,160. The disclosure for this sale can be found here. Insiders have sold 84,060 shares of company stock valued at $22,996,508 over the last three months. 0.80% of the stock is currently owned by insiders.

Institutional Trading of Cigna

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Comprehensive Financial Consultants Institutional Inc. bought a new stake in shares of Cigna in the 4th quarter valued at approximately $78,000. Lloyd Advisory Services LLC. bought a new stake in Cigna in the first quarter valued at $30,000. Benjamin Edwards Inc. raised its stake in Cigna by 150.9% during the fourth quarter. Benjamin Edwards Inc. now owns 138 shares of the health services provider's stock worth $32,000 after acquiring an additional 83 shares in the last quarter. First Foundation Advisors grew its holdings in shares of Cigna by 3.6% in the 1st quarter. First Foundation Advisors now owns 2,110 shares of the health services provider's stock worth $506,000 after purchasing an additional 74 shares during the last quarter. Finally, Convergence Investment Partners LLC increased its position in shares of Cigna by 3.0% during the 1st quarter. Convergence Investment Partners LLC now owns 1,560 shares of the health services provider's stock worth $374,000 after purchasing an additional 46 shares in the last quarter. Institutional investors and hedge funds own 88.57% of the company's stock.

Cigna Company Profile

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Recommended Stories

• Get a free copy of the StockNews.com research report on Cigna (CI)
• Look at Honeywell for a Steady and Diversified Stock
• Why Invest in High-Yield Dividend Stocks?
• Find and Profitably Trade Stocks at 52-Week Lows
• Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
• Solar Stocks Shine Brightly After Passage Of Clean Energy Bill

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.